Researchers sought to determine trends and future patterns for liver, pancreatic, colorectal, stomach, and esophageal cancers in the US.

A new blood test was found to detect colon cancer with more than 80% accuracy — and to rule it out for 90% of healthy people.

Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of ...

Dr. Filippo Pietrantonio discusses OrigAMI-1 trial data which assessed Rybrevant in mutated, wild-type, non-HER2-amplified ...

Perspective Therapeutics shares interim results for [212Pb]VMT-α-NET trial, showing promising safety, stable disease cases, ...

Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in the PI3K ...

A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, potentially improving survival and expanding treatment options. A novel approach ...

Impact of sirtuin genes expression on first-line treatment outcomes in patients (pts) with metastatic colorectal cancer (mCRC) enrolled in CALGB/SWOG 80405 (Alliance). This is an ASCO Meeting Abstract ...

metastatic colorectal cancer (mCRC) treated with immune checkpoint inhibitors (ICI). This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract does not ...

A novel blood-based test for early detection of colorectal cancer in average-risk adults met the primary endpoints of ...

Adults with primary primary appendiceal adenocarcinoma face a higher risk of developing a second primary cancer, including ...

While colon cancer has traditionally been associated with older adults, recent data reveals an alarming trend: cases are ...